Tech & Innovation

How Will Mega M&As Shape Biopharma's Future in 2024?
Tech & Innovation How Will Mega M&As Shape Biopharma's Future in 2024?

As the first quarter of 2024 closed, the biopharma sector wasn't just riding the wave of excitement that accompanies groundbreaking scientific discoveries—it was also navigating the tumultuous waters of the financial markets. With M&A activity surging by a staggering 71 percent in &

Is Oculis Pioneering Genetic-Based Dry Eye Treatment?
Tech & Innovation Is Oculis Pioneering Genetic-Based Dry Eye Treatment?

In the intricate world of biopharmaceuticals, a novel paradigm is emerging that could significantly shift how we approach ocular conditions. At its forefront is Oculis, a company whose innovative exploration into precision medicine might just pave the way for tailored dry eye treatments. Central to

Is Biotech Shifting From Oncology to Autoimmune Research?
Research & Development Is Biotech Shifting From Oncology to Autoimmune Research?

The biotech industry is at a crossroads, grappling with the challenges and expectations set by cell therapies. Oncology-focused treatments that once held great promise are now facing a reality check, prompting many companies to reevaluate their focus on autoimmune diseases. As expectations align

Is Pharma 4.0 the Future of Drug Manufacturing Efficiency?
Management & Regulatory Is Pharma 4.0 the Future of Drug Manufacturing Efficiency?

In the rapidly-changing environment of the pharmaceutical industry, the innovative stride of Pharma 4.0 heralds a new era of drug production. This pivotal shift to smart manufacturing aligns with the principles of Industry 4.0, embedding digitalization and cutting-edge technology to meet the

Retro Biosciences Partners with Multiply Labs for Longevity
Research & Development Retro Biosciences Partners with Multiply Labs for Longevity

Introduction Retro Biosciences, a pioneering biotech company, has embarked on an ambitious journey to extend human lifespan by a decade through innovative approaches to combat cellular aging. Its strategic partnership with Multiply Labs, a firm celebrated for advanced automation and robotic

Surging Lab Automation Market to Hit $11.31B by 2031
Research & Development Surging Lab Automation Market to Hit $11.31B by 2031

The lab automation market is a rapidly growing field, expected to reach a staggering $11.31 billion by 2031. This growth is driven by several factors, including increased R&D spending, the rising prevalence of chronic and infectious diseases, higher demand for lab automation, and significant

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later